Medical devices
Medical device trials in Australia with a local sponsor
Medical device companies often look at Australia for early feasibility, pilot, pivotal, or global clinical investigation activity.
The local sponsor question needs to be answered alongside device risk, evidence, investigator capability, site model, and the Australian pathway.
Short answer
Clintrail can act as the Australian local sponsor for eligible medical device clinical trials, while the overseas device company retains product ownership, design history, technical documentation, clinical strategy, and global development control.
Device context
Device trials need more than a protocol and site list.
Medical device clinical trials often need a clear view of device design, intended use, risk controls, prior bench and animal data where relevant, usability, investigator training, device accountability, and safety reporting interfaces.
For higher-risk or novel devices, the pathway discussion can be more involved. The TGA handbook notes that CTA may be more appropriate where an experimental device introduces new technology, material, or treatment concepts not previously evaluated in clinical trials.
Local sponsor
The Australian sponsor role should match the device risk profile.
The Australian local sponsor needs enough information to understand what is being supplied, how the trial will be conducted, who controls the device, and how safety, records, and escalation will work.
Clintrail can help structure the local sponsor role so the overseas device company keeps technical and global program ownership while the Australian sponsor responsibilities are defined for the local clinical trial.
Documents
What a device sponsor should be ready to discuss.
For an initial discussion, device companies should be ready to describe the device, intended purpose, classification assumptions, development stage, prior evidence, Australian site model, investigator training needs, and current CTN or CTA thinking.
- Investigator's brochure or equivalent device documentation.
- Risk management summary and relevant verification or validation evidence.
- Prior clinical or non-clinical evidence.
- Device supply, storage, accountability, and return or disposal model.
- Safety reporting and escalation model for device-related events.
Practical matrix
Device-trial responsibility split
The exact split depends on the device and clinical investigation. These are common areas to define.
| Area | Clintrail as Australian sponsor | Overseas device company |
|---|---|---|
| Device information | Reviews sponsor implications and required local inputs. | Owns design, manufacture, technical documentation, risk management, and product strategy. |
| Pathway | Supports the Australian sponsor side of CTN or CTA activity where relevant. | Provides evidence, rationale, and technical context for pathway discussions. |
| Site conduct | Maintains sponsor-side visibility of local responsibility boundaries. | Supports training, device handling information, and operational inputs. |
Common questions
Questions overseas teams usually ask
Can Clintrail sponsor implantable device trials?
Clintrail can consider eligible device trials where the device risk, evidence package, pathway, safety reporting, insurance, and sponsor responsibility split can be defined appropriately.
Does Australia use ISO 14155 for device trials?
The TGA recognises ISO 14155 as the relevant good clinical practice guideline for medical device clinical investigations.
Do device trials need an investigator's brochure?
TGA guidance says trials investigating medical devices should have an investigator's brochure or equivalent documentation, regardless of device classification.
Source context
Grounded in Australian clinical trial requirements.
These pages are written for planning clarity. They do not replace legal, tax, regulatory, insurance, ethics, or clinical operations advice for a specific trial.
Related pages
Continue the sponsor-structure research
CTN vs CTA in Australia for overseas sponsors
A practical guide for overseas sponsors comparing Australia's CTN and CTA pathways and understanding where the Australian local sponsor fits.
Australian clinical trial sponsor responsibilities
What overseas sponsors need to understand about the Australian clinical trial sponsor role, sponsor oversight, approvals, safety, records, and responsibility allocation.
IVD and diagnostics trials in Australia with a local sponsor
How overseas diagnostics and IVD companies can structure Australian clinical performance or diagnostics studies with an Australian local sponsor.
Run a clinical trial in Australia without setting up a local entity
How overseas companies can avoid forming an Australian subsidiary solely to hold the clinical trial sponsor role.
Next step
Need an Australian local sponsor?
Send through a short description of the clinical trial and your planned Australian activity. We will review it and get back to you soon.